Danesi R - Search Results

1

Pharmacokinetics and pharmacodynamics of combination chemotherapy with paclitaxel and epirubicin in breast cancer patients.

Danesi R, Innocenti F, Fogli S, Gennari A, Baldini E, Di Paolo A, Salvadori B, Bocci G, Conte PF, Del Tacca M. Danesi R, et al. Br J Clin Pharmacol. 2002 May;53(5):508-18. doi: 10.1046/j.1365-2125.2002.01579.x. Br J Clin Pharmacol. 2002. PMID: 11994057 Free PMC article. Clinical Trial.

2

Characterization of the toxicity of distamycin derivatives on cancer cell lines and rat heart.

Agen C, Sironi AM, Danesi R, Costa M, Bernardini N, Paparelli A, Della Torre P, Del Tacca M. Agen C, et al. Among authors: danesi r. Toxicology. 1992 Nov 15;75(3):209-19. doi: 10.1016/0300-483x(92)90003-w. Toxicology. 1992. PMID: 1455430

3

Reduced cardiotoxicity and increased cytotoxicity in a novel anthracycline analogue, 4'-amino-3'-hydroxy-doxorubicin.

Danesi R, Bernardini N, Agen C, Costa M, Zaccaro L, Pieracci D, Malvaldi G, Del Tacca M. Danesi R, et al. Cancer Chemother Pharmacol. 1992;29(4):261-5. doi: 10.1007/BF00685942. Cancer Chemother Pharmacol. 1992. PMID: 1472260

4

The antiproliferative effect of suramin on the cancer cell line SW-13 is mediated by the inhibition of transforming growth factor beta 1 (TGF-beta 1).

Danesi R, Agen C, Bernardini N, Costa M, Del Tacca M. Danesi R, et al. Pharmacol Res. 1992 Feb-Mar;25 Suppl 1:17-8. doi: 10.1016/1043-6618(92)90519-h. Pharmacol Res. 1992. PMID: 1508796 No abstract available.

5

Doxorubicin cardiotoxicity is associated with alterations of plasma levels of atrial natriuretic factor.

Bernardini N, Agen C, Favilla S, Danesi R, Del Tacca M. Bernardini N, et al. Among authors: danesi r. J Endocrinol Invest. 1992 Feb;15(2):79-84. doi: 10.1007/BF03348668. J Endocrinol Invest. 1992. PMID: 1533234

6

Reducing doxorubicin cardiotoxicity in the rat using deferred treatment with ADR-529.

Agen C, Bernardini N, Danesi R, Della Torre P, Costa M, Del Tacca M. Agen C, et al. Among authors: danesi r. Cancer Chemother Pharmacol. 1992;30(2):95-9. doi: 10.1007/BF00686399. Cancer Chemother Pharmacol. 1992. PMID: 1600601

7

Cardiotoxicity and cytotoxicity of the anthracycline analog 4'-deoxy-4'-iodo-doxorubicin.

Danesi R, Bernardini N, Agen C, Costa M, Macchiarini P, Della Torre P, Del Tacca M. Danesi R, et al. Toxicology. 1991;70(2):243-53. doi: 10.1016/0300-483x(91)90050-b. Toxicology. 1991. PMID: 1763418

8

Differential affinities of AF-DX 116, atropine and pirenzepine for muscarinic receptors of guinea pig gastric fundus, atria and urinary bladder: might atropine distinguish among muscarinic receptor subtypes?

Del Tacca M, Danesi R, Blandizzi C, Bernardini MC. Del Tacca M, et al. Among authors: danesi r. Pharmacology. 1990;40(5):241-9. doi: 10.1159/000138668. Pharmacology. 1990. PMID: 1980366

9

Roxithromycin penetration into gingiva and alveolar bone of odontoiatric patients.

Del Tacca M, Danesi R, Bernardini N, Ducci M, Zolfino I, Senesi S, Panattoni E, Gabriele M, Marcucci M, Lazzarini A, et al. Del Tacca M, et al. Among authors: danesi r. Chemotherapy. 1990;36(5):332-6. doi: 10.1159/000238785. Chemotherapy. 1990. PMID: 2119954

10

Superoxide anion production by doxorubicin analogs in heart sarcosomes and by mitochondrial NADH dehydrogenase.

Gervasi PG, Agrillo MR, Lippi A, Bernardini N, Danesi R, Del Tacca M. Gervasi PG, et al. Among authors: danesi r. Res Commun Chem Pathol Pharmacol. 1990 Jan;67(1):101-15. Res Commun Chem Pathol Pharmacol. 1990. PMID: 2158133

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

525 results

Search Page

Filters